Page last updated: 2024-11-05

trimethobenzamide and Peritonitis

trimethobenzamide has been researched along with Peritonitis in 1 studies

trimethobenzamide: major descriptor (64-84); on-line search BENZAMIDES (64-84); Index Medicus search TRIMETHOBENZAMIDE (64-84); RN given refers to parent cpd
trimethobenzamide : The amide obtained by formal condensation of 3,4,5-trihydroxybenzoic acid with 4-[2-(N,N-dimethylamino)ethoxy]benzylamine. It is used to prevent nausea and vomitting in humans.

Peritonitis: INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
PICHA, E1

Other Studies

1 other study available for trimethobenzamide and Peritonitis

ArticleYear
USE OF A NEW ANTIEMETIC IN GYNECOLOGICAL RADIATION THERAPY.
    Applied therapeutics, 1964, Volume: 6

    Topics: Antiemetics; Benzamides; Gynecology; Humans; Intestinal Obstruction; Peritonitis; Radioisotopes; Rad

1964